ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
ALX Oncology appointed Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel, effective immediately. Mr. Garland succeeds co-founder Corey Goodman, who stepped down after more than a decade; Mr. Garland has served on the board since 2022.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.